未知生产厂商
Neflamapimod has been used in trials studying the treatment of Alzheimer's Disease and Mild Cognitive Impairment.
Neflamapimod has been used in trials studying the treatment of Alzheimer's Disease and Mild Cognitive Impairment.
Neflamapimod is an investigational, orally administered small-molecule drug that readily crosses the blood-brain barrier and selectively inhibits the alpha isoform of p38 MAP kinase (p38α), a key driver of neuroinflammation and synaptic dysfunction.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
